| 1 |
35486975 | Dexmedetomidine attenuates perioperative neurocognitive disorders by suppressing hippocampal neuroinflammation and HMGB1/RAGE/NF-κB signaling pathway. | 2022 Jun |
3 |
| 2 |
33748118 | Abnormal Rat Cortical Development Induced by Ventricular Injection of rHMGB1 Mimics the Pathophysiology of Human Cortical Dysplasia. | 2021 |
2 |
| 3 |
34162568 | Dexmedetomidine Attenuates Myocardial Injury Induced by Renal Ischemia/Reperfusion by Inhibiting the HMGB1-TLR4-MyD88-NF-κB Signaling Pathway. | 2021 May |
1 |
| 4 |
34196265 | Dexmedetomidine inhibits inflammatory response and oxidative stress through regulating miR-205-5p by targeting HMGB1 in cerebral ischemic/reperfusion. | 2021 Aug |
7 |
| 5 |
31912804 | Dexmedetomidine Post-Conditioning Alleviates Cerebral Ischemia-Reperfusion Injury in Rats by Inhibiting High Mobility Group Protein B1 Group (HMGB1)/Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB) Signaling Pathway. | 2020 Jan 8 |
4 |
| 6 |
32607919 | Dexmedetomidine Alleviates CCI-Induced Neuropathic Pain via Inhibiting HMGB1-Mediated Astrocyte Activation and the TLR4/NF-κB Signaling Pathway in Rats. | 2020 Oct |
5 |
| 7 |
32707303 | Dexmedetomidine ameliorates renal ischemia reperfusion-mediated activation of the NLRP3 inflammasome in alveolar macrophages. | 2020 Oct 20 |
2 |
| 8 |
31344138 | Dexmedetomidine-induced cardioprotection is mediated by inhibition of high mobility group box-1 and the cholinergic anti-inflammatory pathway in myocardial ischemia-reperfusion injury. | 2019 |
4 |
| 9 |
29241031 | The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways. | 2018 Feb |
1 |
| 10 |
27998004 | Dexmedetomidine preconditioning for myocardial protection in ischaemia-reperfusion injury in rats by downregulation of the high mobility group box 1-toll-like receptor 4-nuclear factor κB signalling pathway. | 2017 Mar |
4 |
| 11 |
28222157 | Dexmedetomidine preconditioning may attenuate myocardial ischemia/reperfusion injury by down-regulating the HMGB1-TLR4-MyD88-NF-кB signaling pathway. | 2017 |
5 |
| 12 |
29312480 | Dexmedetomidine mitigates CLP-stimulated acute lung injury via restraining the RAGE pathway. | 2017 |
1 |
| 13 |
26418907 | Stimulation of Central α2 Receptors Attenuates Experimental Necrotizing Pancreatitis. | 2016 Feb |
1 |
| 14 |
26408618 | [Effect of dexmedetomidine on high-mobility group box 1 protein in rats with sepsis]. | 2015 Sep |
5 |